Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 1Dermatologic 1

Conditions

Colorectal Neoplasms 2Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Precancerous Conditions 1Pancreatitis, Chronic 1Pancreatic Neoplasms 1Pain 1Neoplasms 1Mycosis Fungoides 1Lymphoma, T-Cell, Cutaneous 1Lymphoma, T-Cell 1Lymphoma, Mantle-Cell 1Lymphoma, B-Cell, Marginal Zone 1Lymphedema 1Leukemia, Myeloid, Acute 1Leukemia, Myelogenous, Chronic, BCR-ABL Positive 1Leiomyoma 1Keratosis, Actinic 1Hodgkin Disease 1Dermatitis, Contact 1Dendritic Cell Sarcoma, Interdigitating 1Chalazion 1Carcinoma, Basal Cell 1Burkitt Lymphoma 1Breast Neoplasms 1Breast Cancer Lymphedema 1Anemia, Refractory, with Excess of Blasts 1Adenomyosis 1

Interventions

Triamcinolone Acetonide 1Triamcinolone 1Ointments 1Mechlorethamine 1Gels 1Gelatin 1Docosahexaenoic Acids 1Biopsy 1Amines 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Dermatitis, Contact × Triamcinolone × Clear all
NCT03380026 2021-11-24

MIDAS

Rochester Skin Lymphoma Medical Group, PLLC

Phase 2 Completed
28 enrolled 8 charts
DermatologicLymphoid

Dermatitis, Contact, Mycosis Fungoides, Lymphoma, T-Cell, Cutaneous

Data powered by HemOnc (CC BY 4.0) Colophon âš¡